Leading institutions in the UK, including the Wellcome Trust, have announced plans to create a repository of induced pluripotent stem cells (iPS) in order to study how genetic variation and defects impact cell behaviour and disease. ---Subscribe to MedNous to access this article--- Regenerative Medicine Research & University News
